Are left ventricular ejection fraction phenotypes meaningful in acute heart failure?

Article Cardiac & Cardiovascular Systems

Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF

Dimitrios Farmakis et al.

Summary: This study analyzed healthcare resource utilization in patients with heart failure of different ejection fraction types and found high utilization across all three groups. Despite clinical differences, patients with HFmrEF and HFpEF had better long-term cardiovascular outcomes compared to HFrEF. However, the risk for non-cardiovascular events was similar among the groups.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Theresa A. McDonagh et al.

Summary: All experts involved in the development of the guidelines have declared their interests, and the declarations have been compiled and published in a supplementary report. The report can be accessed on the ESC website. The supplementary data provide background information and detailed discussion of the data that form the basis for the guidelines.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

添加到收藏夹

Article Medicine, General & Internal

Safety, tolerability, and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Alexandre Mebazaa et al.

Summary: This study aimed to investigate the impact of guideline-directed medical therapy dose and up-titration pace on the efficacy and safety of patients admitted to the hospital for acute heart failure. The results showed that compared with usual care, high-intensity care significantly reduced the risk of heart failure readmission or all-cause death within 180 days.

LANCET (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study

Michele Senni et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

添加到收藏夹

Article Medicine, General & Internal

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Paul W. Armstrong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry

Ovidiu Chioncel et al.

EUROPEAN JOURNAL OF HEART FAILURE (2017)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

REPORT-HF: the unique blend of global heart failure registry and longitudinal cohort study

Stephen J. Greene et al.

EUROPEAN JOURNAL OF HEART FAILURE (2015)

添加到收藏夹

Are left ventricular ejection fraction phenotypes meaningful in acute heart failure?

相关参考文献

Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF

Safety, tolerability, and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry

REPORT-HF: the unique blend of global heart failure registry and longitudinal cohort study

导出引文

分享论文